Page 432 - IJB-9-3
P. 432

International Journal of Bioprinting              Gelatin-PVA crosslinked genipin bioinks for skin tissue engineering


            bioprinting. Besides having excellent capability to   (GE) powder from (Nitta-Gelatin Ltd., Osaka, Japan)
            improve mechanical strength, high swelling ratio, as   was weighed and added to the dissolved PVA mixture
            well as the attributes of being biocompatible and non-  after  the temperature cooled  down  at  40°C  and  stirred
            toxic, PVA also has the benefit of post-polymerization   for 30  min until fully dissolved. Next, 0.1% of genipin
            modification because of its secondary hydroxyl groups.   (GNP) (FUJIFILM Wako Pure Chemical Corporation,
            On the other hand, PVA has limitations in cell-    Japan) was prepared by dissolving 0.01 g (w/v) of GNP
            biomaterial interactions and should be supplemented   powder in 70% of ethanol (EtOH; MERCK, Darmstadt,
            with  other  tissue-inducing  materials  to  speed  up  the   Germany). After the mixture became homogenous, the
            healing process [23] . Other research has shown that PVA   GNP was added into the GPVA mixture to obtain a
            has low protein affinities, which restrict cell binding   final  formulation  of  GE_GNP  (0.1% GNP),  GPVA3_
            or attachment and potentially lead to a rounded    GNP (3% PVA _0.1% GNP), and GPVA5_GNP (5%
            morphology. Therefore, this study incorporated PVA   PVA_0.1% GNP) while the non-crosslinked hydrogels
            with gelatin to provide a conducive environment for   were represented as GE_NC, GPVA3_NC (3% PVA), and
            cells to survive due to an arginine-glycine-aspartic acid   GPVA5_NC (5% PVA).
            integrin-binding sequence in the gelatin that involves
            both the A-chain and the B-chain [24] .            2.2. Synthesis of gelatin-PVA composite bioinks
              The crosslinking process is one of the sustainable and   Sterilized bioinks were prepared under the biosafety
            well-known approaches to ensuring excellent stability   cabinet to maintain sterility using sterilized GE and PVA
            of  fabricated  bioscaffolds  before  implantation. It  can   powder. Next,  autoclaved distilled  water (dH O) was
                                                                                                      2
            be divided into irradiation-, physical-  and chemical-  used to dissolve the PVA powders at 60°C followed by
            based methods. Genipin derived from the  Gardenia   dissolving the GE powder at 40°C. Sterilized GNP powder
            jasminoides plant was used in fabricating gelatin-  was dissolved in 70% ethanol before adding into the
            PVA hydrogels as a crosslinking agent. It was utilized   GPVA solution to obtain different hydrogels formulation
            as  a  crosslinking  agent  due  to  its  potential  to  increase   GE_GNP, GPVA3_GNP, and GPVA5_GNP solution.
            mechanical strength, stability and non-toxicity [25] .   Dissolved GPVA solutions were thoroughly mixed with
            Briefly, the genipin combines with primary amine   human dermal fibroblasts (HDFs) with 1.5 × 10  of cell
                                                                                                       6
            groups to fix biological tissues, and it is substantially   density per mL of gels for the subsequent 3D bioprinting
            less harmful than other chemical crosslinkers, such   process.
            as glutaraldehyde, diisocyanates, and epoxides [26] .
            This study aims to develop a simple, accessible, and   2.3. 3D bioprinting of gelatin-PVA hydrogel
            reproducible bioinks formulation for wound healing   A model was built by Autodesk fusion 360 software (stl.
            applications, and to evaluate the influence of genipin   file format). The pre-defined structures were input into
            as a chemical crosslinker against gelatin-PVA bioinks.   Simplify3D software (version  4.1). A  3D bioprinter,
            Besides, the physicochemical and rheological properties   Biogens XI (3D Gens, Malaysia), was used to print GPVA
            of the bioinks were evaluated after fabricated via 3D   bioinks. Sterilized GPVA bioinks were loaded into a
            bioprinting approach. Finally, by varying the amount of   sterilized printing syringe (inner diameter: 0.3  mm) at
            PVA, this study aims to identify a composite bioscaffold   the tip, and the printing process was conducted using an
            with acceptable performance and biocompatibility for   extrusion-based  printhead.  The  hydrogel  was  deposited
            skin tissue engineering through in  vitro testing.  via an extrusion-based bioprinting approach, and the
                                                               material flow for the printhead was controlled by pressure
            2. Materials and methods                           regulators. The printability of different GPVA hydrogels
            The study design was approved by the Universiti    was evaluated using a combination of different printing
            Kebangsaan Malaysia Research Ethics Committee      temperatures (27 – 19°C) and speed rates (4000  mm/s)
            (Code  no. FF-2021-376 and JEP-2021-605). The research   using a constant nozzle diameter of 0.3 mm. The adjacent
            was performed in certified facilities under ISO 9001:2015   filaments were printed with 2.5 cm in length at 0.3 mm
            quality management system.                         of retraction. Multi-layer layered hydrogel construct
                                                               with grid-like patterns was fabricated by printing each
            2.1. Preparation of gelatin-PVA hydrogels          layer of grid-like patterns directly over the previous layer
            0.3 g and 0.5 g of PVA powder (MERCK KGaA, Germany;   using an optimal combination of speed rates and printing
            partially hydrolyzed [≥85%], MW 70,000  g/mol) were   temperature. Figure 1 demonstrates the functional block
            dissolved in 10 mL of distilled water (dH O) for 1 h at 60°C   diagram for 3D bioprinting process from the beginning
                                            2
            to obtain 3% and 5% (w/v) concentration. 6 g of gelatin   until 3D model is constructed.

            Volume 9 Issue 3 (2023)                        424                          https://doi.org/10.18063/ijb.677
   427   428   429   430   431   432   433   434   435   436   437